For example, Kelly et al showed that hepsin-targeting peptides conjugated to cross-linked iron oxides NPs improved NP tumor accumulation in hepsin expressing prostate tumor xenografts compared to non-targeted NPs 135 (Figure 6A). This evidence concerns the gene HPN and prostate neoplasm.